Dominant lethal study in male mice treated with ofloxacin, a new antimicrobial drug

Arnold, 1976, Dominant studies with alkylating agents: dose-response relationship, Toxicol. Appl. Pharmacol., 38, 79, 10.1016/0041-008X(76)90162-9 Brewen, 1975, Studies on chemically induced dominant lethality, I. The cytogenetic basis of MMS-induced dominant lethality in postmeiotic male germ cells, Mutation Res., 38, 239, 10.1016/0027-5107(75)90200-6 Burki, 1978, Expression of TEM-induced damage to postmeiotic stages of spermatogenesis of the mouse during early embryogenesis, II. Cytological investigations, Mutation Res., 52, 107, 10.1016/0027-5107(78)90099-4 Ehling, 1978, Standard protocol for the dominant lethal test on male mice, Set up by work group “Dominant lethal mutations on the ad hoc committe chemogenetics”, Arch. Toxicol., 39, 173, 10.1007/BF00368226 Epstein, 1972, Detection of chemical mutagens by the dominant lethal assay in the mouse, Toxicol. Appl. Pharmacol., 23, 288, 10.1016/0041-008X(72)90192-5 Goldstein, 1977, Methyl methanesulfonate-induced dominant lethal mutations in male mice detected in vitro, Mutation Res., 42, 135, 10.1016/S0027-5107(77)80017-1 Green, 1976, Protocols for the dominant lethal test, host-mediated assay and in vivo cytogenetic test used in the Food and Drug Administration's review of substances in the GRAS (generally recognized as safe) list, J. Toxicol. Environ. Health., 1, 921, 10.1080/15287397609529394 Irikura, 1981, Mutagenicity studies of AM-715 in animals, Chemotheraphy, 29 S-4, 932 Kratochvilova, 1978, Evaluation of pre-implantation loss in dominant-lethal assay in the mouse, Mutation Res., 54, 47, 10.1016/0165-1161(78)90134-6 Oakberg, 1956, Duration of spermatogenesis in the mouse and timing of stage of the cycle of the seminiferous epithelium, Am. J. Anat., 99, 507, 10.1002/aja.1000990307 Ohno, 1984, Acute toxicity study of DL-8280, a new synthetic antibacterial agent, in mice, rats, dogs, and monkeys, Chemotheraphy, 32, 1084 Röhrborn, 1970, The dominant lethals: Method and cytogenetic examination of early cleavage stages, 148 Sato, 1982, In vitro and in vivo activity of DL-8280, a new oxazine derivative, Antimicrob. Agents Chemother., 22, 548, 10.1128/AAC.22.4.548 Shimada, 1979, The sensitivity of MMS induced dominant lethal mutations in ddY strain mice Shimada, 1980, Lack of induction of dominant lethal mutations in male mice by nalidixic acid, Toxicol. Lett., 7, 165, 10.1016/0378-4274(80)90051-X Shimada, 1984, Mutagenicity studies of DL-8280, a new antibacterial drug, Chemotheraphy, 32 S-1, 1162 Tokunaga, 1979, Dominant lethal mutation test of miloxacin, a new synthetic antibacterial agent, Pharmacometrics, 18, 37